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Abstract
Anthrax is a potentially fatal disease resulting from infection with Bacillus anthracis. The outcome of infection is influenced
by pathogen-encoded virulence factors such as lethal toxin (LT), as well as by genetic variation within the host. To identify
host genes controlling susceptibility to anthrax, a library of congenic mice consisting of strains with homozygous
chromosomal segments from the LT-responsive CAST/Ei strain introgressed on a LT-resistant C57BL/6 (B6) background was
screened for response to LT. Three congenic strains containing CAST/Ei regions of chromosome 11 were identified that
displayed a rapid inflammatory response to LT similar to, but more severe than that driven by a LT-responsive allele of the
inflammasome constituent NRLP1B. Importantly, increased response to LT in congenic mice correlated with greater
resistance to infection by the Sterne strain of B. anthracis. The genomic region controlling the inflammatory response to LT
was mapped to 66.36–74.67 Mb on chromosome 11, a region that encodes the LT-responsive CAST/Ei allele of Nlrp1b.
However, known downstream effects of NLRP1B activation, including macrophage pyroptosis, cytokine release, and
leukocyte infiltration could not fully explain the response to LT or the resistance to B. anthracis Sterne in congenic mice.
Further, the exacerbated response in congenic mice is inherited in a recessive manner while the Nlrp1b-mediated response
to LT is dominant. Finally, congenic mice displayed increased responsiveness in a model of sepsis compared with B6 mice. In
total, these data suggest that allelic variation of one or more chromosome 11 genes in addition to Nlrp1b controls the
severity of host response to multiple inflammatory stimuli and contributes to resistance to B. anthracis Sterne. Expression
quantitative trait locus analysis revealed 25 genes within this region as high priority candidates for contributing to the host
response to LT.
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Introduction
Microbial pathogens have evolved various mechanisms to block
host immune responses and thereby increase virulence. The MAP
kinase (MAPK) signaling pathways have a central role in innate
immune responses mounted by both plants and animals, and are
common targets that are inactivated by a variety of bacterial toxins
and effector molecules [1,2]. B. anthracis produces anthrax lethal
toxin (LT), a bipartite toxin that contributes to immunosuppres-
sion and pathology in the host [3]. The catalytic moiety of anthrax
LT, lethal factor (LF), is a zinc-dependent metalloprotease that
cleaves the N-termini of MAPK kinases (MKKs). By inactivating
MKKs, LT blocks production of proinflammatory chemokines
and cytokines such as TNF-a and inhibits survival signals activated
via downstream MAPKs [4–11]. Thus, LT-mediated cleavage of
MKKs leads to the silencing of a pro-inflammatory response,
effectively repressing host immunity and favoring bacterial survival
[9,12,13].
In response to such pathogenic mechanisms, eukaryotic hosts
have evolved means to detect and counter pathogen encoded
virulence factors that target intracellular signaling pathways.
Specifically, nucleotide-binding domain leucine-rich repeat
(NLR) proteins sense bacterial products or host cell-derived
danger signals to initiate defense pathways. NLR-mediated
responses can function locally through induction of cell death
and/or distally through production and release of antimicrobial
products and signaling molecules. Allelic variation at the NLR
gene, Nlrp1b, in rodents is one mechanism that controls the host
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infection [14–16]. Specifically, LT-responsive alleles of Nlrp1b
drive caspase-1 mediated proinflammatory cell death, termed
pyroptosis, of macrophages and dendritic cells. Increased resis-
tance to B. anthracis is correlated with LT activation of the
NLRP1B inflammasome, resulting in IL-1b release and pyroptosis
[15,17].
Sensitivity of multiple animal species to anthrax varies inversely
with sensitivity to injection of purified LT [18]. This inverse
relationship holds true when comparing inbred strains of mice
[19]. Therefore, genetic comparison of mouse strains is predicted
to reveal mechanisms of the host response to B. anthracis. Indeed,
differential sensitivity of mouse strains to B. anthracis infection is
known to be influenced by allelic variations in at least two genes:
Nlrp1b and Hc encoding complement C5 [15,17,19–23]. Allelic
variation of these genes does not, however, fully account for
differential sensitivity to infection or to intoxication by LT [17,24].
Therefore, we hypothesized that additional genes may contribute
to host susceptibility to anthrax. Due to the critical role of LT as a
virulence determinant for B. anthracis, a genome-wide collection of
congenic mouse strains was screened for altered responses to this
toxin. Here we report the identification of a quantitative trait locus
(QTL) on chromosome 11 that influences host response to
multiple inflammatory stimuli including LT, resulting in increased
resistance to B. anthracis Sterne infection.
Results
CAST/Ei Alleles on Chromosome 11 Are Associated with a
Rapid and Severe Inflammatory Response to LT and
Endotoxin
To identify chromosomal regions affecting response to LT, a
library of congenic mice consisting of homozygous CAST/Ei
segments on a B6 background was screened. The genome
coverage of this library spans roughly 80% of the autosomal
chromosomes and consists of approximately three strains per
chromosome in which CAST/Ei segments are introgressed onto
the C57BL/6J (B6) background in an overlapping manner [25].
Three strains, B6.CAST.11 medial (B6.CAST.11M), B6.CAST.11
proximal medial (B6.CAST.11PM), and B6.CAST.11 complete
(B6.CAST.11C), all harboring CAST/Ei segments on chromo-
some 11, displayed a rapid and transitory response following LT
injection similar to the early response phenotype (ERP) previously
observed in LT-challenged B6
Nlrp1b(129S1) transgenic mice [15].
The latter express a 129S1/SvImJ(129S1)-derived LT-responsive
allele of Nlrp1b on an otherwise LT-resistant B6 background. Akin
to the ERP of LT-injected B6
Nlrp1b(129S1) transgenic mice,
chromosome 11 B6.CAST mice presented with ataxia
(Figure 1A), hypothermia (Figure 1B) and one or more of the
following: bloat, dilated vessels on pinnae, loose/watery feces,
labored abdominal breathing (not shown). This response devel-
oped as early as 30 min post LT injection, and all animals
presented by 4 h (not shown). Importantly, the ERP displayed by
chromosome 11 B6.CAST mice was significantly more pro-
nounced compared to that in B6
Nlrp1b(129S1) animals as evidenced
by a more severe ataxia score (Figure 1A) as well as a more severe
hypothermic state (Figure 1B). Other congenic strains and B6
mice did not display clinical signs associated with the ERP (data
not shown). Upon careful observation, CAST/Ei and BALB/c
strains displayed a very mild, inconsistent version of these early
signs (data not shown), indicating that the mixture of CAST/Ei
alleles of chromosome 11 genes with B6 alleles accounting for the
rest of the genome likely resulted in increased expressivity of a
toxin-responsive phenotype present in LT-responsive strains. The
response to LT was independent of route of toxin administration
and was present when mice were administered toxin intravenously
(i.v.) (not shown). Interestingly, i.v. LT challenge produced an
accelerated presentation of the ERP that was observed as quickly
as 18 min post challenge (not shown). Following the ERP,
chromosome 11 B6.CAST mice typically recovered to normal
behavior within 4–25 h post LT injection and subsequently
relapsed into a second round of clinical signs, eventually
succumbing to moribund state and/or death within the same
timeframe as parental B6 mice (Figure 1C, and not shown).
Endotoxin contamination of protective antigen (PA), the host cell-
binding moiety of LT, or LF was not responsible for the ERP or
ultimate lethality, as no response was detected following injection
of a 2X dose of individual toxin components (data not shown).
Anthrax LT induces a rapid pyroptotic cell death in
macrophages derived from mice with LT-responsive alleles of
Nlrp1b. Five murine alleles of Nlrp1b have been described [14].
Allele 2, encoded by B6 mice, and alleles 3 and 4 do not respond
to LT, while allele 1, encoded by 129S1 and Balb/C mice, and
allele 5, encoded by CAST/Ei mice, are LT-responsive.
Responsiveness to LT is fully dominant and macrophages from
heterozygous mice with one LT-responsive and one LT-resistant
allele display sensitivity to LT indistinguishable from macrophages
encoding two LT-responsive alleles ([26] and data not shown). The
kinetics of ERP in mice is consistent with timing of macrophage
and DC pyroptosis treated with LT ex vivo. Therefore, we sought to
determine whether allelic variation of Nlrp1b influenced sensitivity
of macrophages to LT. Bone marrow derived macrophages
(BMDMs) from B6
Nlrp1b(129S1) and B6.CAST.11M mice, as well as
those from BALB/c mice encoding an LT-sensitive allele of Nlrp1b
(allele 1) displayed similar sensitivity to LT ex vivo (Figure 1D).
Further, BMDMs from B6
Nlrp1b(129S1) and B6.CAST.11M mice
displayed similar IL-1b responses to LT (Figure 1F). Together,
these data demonstrate that the more severe ataxia and
hypothermia observed in B6.CAST.11M mice did not result from
alterations in LT-induced macrophage pyroptosis.
We next tested whether B6.CAST.11M mice have an altered
response to additional inflammatory stimuli. Preliminary studies
Author Summary
We show that genetic variation within an 8.3 Mb region on
mouse chromosome 11 controls host response to anthrax
lethal toxin (LT) and resistance to infection by the Sterne
strain of Bacillus anthracis. Specifically, congenic C57BL/6
mice in which this region of chromosome 11 is derived
from a genetically divergent CAST/Ei strain presented with
a rapid and strong innate immune response to LT and
displayed increased survival following infection with
Sterne spores. CAST/Ei chromosome 11 encodes a
dominant LT-responsive allele of Nlrp1b that may partially
account for the severe response to LT. However, the
strength of this response was attenuated in mice with only
one copy of chromosome 11 derived from CAST/Ei
indicating the existence of a recessive modifier of the
inflammatory response to LT. In addition, congenic mice
displayed a pronounced immune response using an
experimental model of sepsis, indicating that one or more
genes within the chromosome 11 region control host
response to multiple inflammatory stimuli. Analyzing the
influence of allelic variation on gene expression identified
25 genes as candidates for controlling these responses. In
summary, we report a genetic model to study inflamma-
tory responses beneficial to the host during anthrax.
Host Genetic Control in Anthrax and Inflammation
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ataxia and clinical signs associated with inflammation following
challenge with recombinant IL-1b (not shown). To further text
LT-independent inflammatory responses, an established model of
sepsis was employed whereby mice were injected i.p. with
muramyl dipeptide (MDP) and lipopolysaccharide (LPS), resulting
in a rapid TNFa-dependent hypothermia [27]. Using this model,
B6.CAST.11M mice displayed exacerbated ataxia (not shown) and
hypothermia (Figure 1E) compared to B6 control animals. This
response was not due to alterations in macrophage responsiveness
to MDP/LPS as determined by TNFa and IL-1b release
(Figure 1F). These results are consistent with a heightened
responsiveness of CAST/Ei chromosome 11 alleles to multiple
inflammatory stimuli.
Previously, we reported that the LT-induced ERP in
B6
Nlrp1b(129S1) mice was associated with release of proinflammatory
cytokines [15]. To determine whether a proinflammatory cytokine
response also accompanies the LT-induced ERP phenotype in
chromosome 11 B6.CAST mice, sera from LT-challenged animals
were analyzed. As predicted, proinflammatory cytokines previous-
ly identified as induced in B6
Nlrp1b(129S1) mice were also induced in
B6.CAST.11M mice following LT challenge (Figure 2A). Inter-
estingly, these cytokines were induced to a similar level and with
similar kinetics in both strains despite the exacerbated ERP
displayed by B6.CAST.11M mice compared to B6
Nlrp1b(129S1) [15].
This finding is consistent with the observation that BMDMs
derived from these strains displayed similar pyroptotic responses to
LT (Figure 1D, F). Endotoxin contamination of PA or LF was
not responsible for the cytokine induction observed, as no response
was detected following injection of a 2X dose of individual toxin
components (not shown). To further test whether alterations in
cytokine responses could explain the altered phenotype severity, a
panel of additional cytokines and chemokines were assayed
following LT challenge (Figure 2B–D). A total of 27 cytokines
were induced in B6.CAST.11M and/or B6
Nlrp1b(129S1) but not B6
mice (Figure 2A –C), while five cytokines showed no response in
any strain (Figure 2D). Only four out of 27 cytokines that
responded to LT were differentially induced in the sera from
B6
Nlrp1b(129S1) mice compared to sera from B6.CAST.11M mice
(Figure 2C). Interestingly, all four of these cytokines were
preferentially induced in B6
Nlrp1b(129S1) mice compared to
B6.CAST.11M mice. Of the cytokines differentially induced,
three function as pro-inflammatory mediators while one cytokine,
IL-4, exhibits both pro- and anti-inflammatory properties [28].
Role of IL-4 and IL-1 in ERP
B6.CAST congenic strains displaying the LT-mediated ERP
share a CAST/Ei derived critical region between 43–107 Mb on
chromosome 11 (Figure 3A). A single cytokine, IL-4, preferen-
tially induced in B6
Nlrp1b(129S1) mice during the LT-induced ERP
relative to B6.CAST.11M mice (Figure 2C) maps to this critical
region and is encoded at 53.4 Mb on chromosome 11.
Interestingly, IL-4 functions as a Th2 cytokine, and elevated
expression of IL-4 has been linked to reduced inflammation during
sepsis in humans [29]. To determine the role of IL-4 in the
inflammatory response to LT, mice deficient in IL-4 but
expressing a LT-responsive allele of Nlrp1b were generated and
tested for their response to LT. If reduced IL-4 levels in
B6.CAST.11M mice are responsible for the exacerbated LT-
induced ERP, then B6
Nlrp1b(129S1);IL42/2 mice would be predicted
to display a strong ERP akin to that in B6.CAST.11M mice.
However, B6
Nlrp1b(129S1);IL42/2 mice displayed an ERP equal in
strength to B6
Nlrp1b(129S1) mice following LT injection (Figure 3B),
indicating that the absence of IL-4 does not affect ERP severity
following LT challenge.
Nlrp1b inflammasome activation results in ASC-dependent
maturation of cytokines including IL-1b, as well as ASC-
independent cell lysis [30]. The ERP is associated with high
serum concentrations of multiple cytokines, of which IL-1b is one
of the earliest detectable (Figure 2A). To determine whether IL-
1b is required for the ERP, B6.CAST.11M, and B6
Nlrp1b(129S1)
mice were pretreated with a blocking antibody to IL-1b, then
challenged with LT. Notably, this treatment had no significant
effect on ERP as determined by ataxia scoring (not shown).
However, it remained possible that the anti IL-1b antibody
treatment was not sufficient to block the LT-induced release of this
cytokine. Therefore, mice deficient in the type 1 IL-1 receptor (IL-
1R) and expressing the LT-responsive 129S1 allele of Nlrp1b were
tested for response to LT. Consistent with the antibody studies, IL-
1R deficient B6
Nlrp1b(129S1) animals displayed ataxia (not shown)
and hypothermic responses indistinguishable from B6
Nlrp1b(129S1)
mice (Figure 3C).
B6.CAST. 11M Mice Display Resistance to Infection by
Bacillus anthracis Sterne Strain
Presentation of the ERP in response to LT correlates with an
increased resistance to B. anthracis Sterne infection [15]. To
determine whether the more severe ERP displayed by chromo-
some 11 B6.CAST mice correlates with an increased resistance to
B. anthracis spore challenge, B6.CAST.11M, B6
Nlrp1b(129S1), and B6
mice were challenged i.p. with 3610
7 Sterne strain spores. At this
dose, all B6.CAST.11M and B6
Nlrp1b(129S1) mice survived to the
experimental endpoint whereas the majority of B6 animals
succumbed to the infection (Figure 4A). Using a ,13 fold higher
dose of 4610
8 Sterne spores revealed that B6.CAST.11M mice
were significantly more resistant to infection compared to
Figure 1. Identification of severe early response phenotype in B6.CAST.11 mice. B6.CAST.11M mice (n=16), B6.CAST.11PM mice (n=5),
B6.CAST.11C mice (n=5), mice expressing a LT-sensitive allele of Nlrp1b (B6
Nrlp1b(129S1)) (n=15), or control B6 animals (n=6) were injected i.p. with
5 mgP A +2.5 mg LF per g body weight and were scored for ataxia severity (A) and survival (C). A, Animals were scored on a 0–3 scale in which
numbers represent the following walking ataxia scores: 0= no ataxia; 1= mild; 2= moderate; 3= severe, immobile, or moribund. See Materials and
Methods for the definition of the ataxia scoring scale. The highest ataxia score during 7 h post injection is plotted +/2 SD. P values calculated by
Kruskal-Wallis nonparametric test with Dunn’s post test. *p,0.05; **p,0.01 compared with B6. B, B6.CAST.11M (n=22), B6
Nrlp1b(129S1) (n=10), or
control B6 animals (n=9) were challenged i.p. with 15 mgP A +7.5 mg LF per g body weight (equivalent in activity to dose used in A, C) and the lowest
temperature observed during the first 5 h post toxin injection is plotted. ***p,0.001 calculated by 1-way ANOVA with Tukey post test. C, Animals
were monitored for presentation of clinical signs associated with terminal LT-induced disease and euthanized upon reaching a moribund state. Data
represent time to euthanasia following LT injection. Symbols represent: squares, B6 (n=6); triangles, B6.CAST.11M (n=16). D, BMDMs derived from
the indicated mouse strains were seeded in 96-well plates and treated with increasing concentrations of PA and LF for 4 h. Viability was assessed
using ATPlite 1-step reagent (Perkin Elmer). Average luminescence values of triplicate samples are graphed +/2 SEM. E, Mice (n=5 / group) were
injected i.p. with 5 mg/g MDP 4 h prior to i.p. challenge with 1 mg/g LPS. Rectal temperature was then measured hourly, and the lowest body temp
achieved by each animal within 4 h is graphed +/2 SD. P-value was calculated from unpaired two-tail t-test. F. BMDMs derived from the indicated
mouse strains were seeded in 96-well plates then challenged with 250 ng/mL LT for 3 h or 0.1 mg/mL MDP +0.1 ng/mL LPS for 8 h. Culture
supernatants were then analyzed for IL-1b and TNFa as described in methods. Data represent average values +/2 SD.
doi:10.1371/journal.ppat.1002469.g001
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Nlrp1b(129S1) mice (Figure 4B). Therefore, a more robust ERP
correlates with increased protection from B. anthracis Sterne
infection. Further, allelic variation of a chromosome 11– encoded
gene(s) contributes to the increased ability of B6.CAST.11M
congenic mice to limit B. anthracis Stern infection.
To determine the cellular mediators providing infection
resistance, mice were challenged with Sterne spores i.p. and
peritoneal exudates were collected and analyzed at various time
points following challenge. A significant increase in the number of
PMNs was observed in both B6
Nlrp1b(129S1) and B6.CAST.11M
mice at earlier time points following spore challenge compared to
nontransgenic (i.e. B6) control mice (Figure 4C). These results
correspond to previously reported data indicating a role for PMNs
in bacterial clearance following B. anthracis spore challenge
[12,15,21]. However, no significant differences were observed in
the PMN response between B6
Nlrp1b(129S1) and B6.CAST.11M
mice that could explain their differential resistance to B. anthracis.
Indeed, at 4 h, neutrophil influx in B6
Nlrp1b(129S1) animals was
significantly greater than that in B6.CAST.11M mice (p=0.04).
Similarly, monocytic infiltration could not explain the increased
resistance seen in B6.CAST.11M mice (Figure 4D).
Given that leukocyte infiltration did not account for the
difference in susceptibility to B. anthracis, we next considered
whether the differential cytokine response could explain the
increased resistance in B6.CAST.11M animals. Although IL-4 did
not contribute to hypothermia (Figure 3B) or ataxia (not shown)
Figure 2. Evaluation of cytokine profile during the LT-induced Early Response Phenotype. B6.CAST.11M (circles), B6
Nrlp1b(129S1) (triangles),
or nontransgenic littermate control mice (squares) were challenged with LT as in Figure 1B. Uninjected animals served as t=0 controls. Animals were
sacrificed at 0.5, 1, 2, and 4 h post toxin injection, and serum cytokines levels were measured. Data represent the average values of five animals per
group +/2 SD. A–B, Several proinflammatory cytokines were induced in B6.CAST.11M and B6
Nrlp1b(129S1) mice that were not induced in nontransgenic
B6 control animals. See [15] for B6
Nrlp1b(129S1) responses for cytokines in (A). C, Cytokines differentially induced in B6
Nrlp1b(129S1) mice compared to
B6.CAST.11M mice. D, Cytokines not induced in either B6.CAST.11M or B6
Nrlp1b(129S1) mice.
doi:10.1371/journal.ppat.1002469.g002
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affected resistance to spore challenge. Indeed, as a Th2 cytokine,
IL-4 can function by altering PMN and macrophage activity
[31,32]. Alteration of phagocyte function may contribute to
differential responses in long-term studies such as resistance to
spore challenge, but not contribute to immediate phenotypes such
as ataxia and hypothermia following LT challenge (Figure 3B).
To test the role of IL-4 in resistance to B. anthracis,
B6
Nlrp1b(129S1);IL42/2 mice were challenged i.p. with Sterne strain
spores (Figure 4E). IL-4 deficiency did not affect host
susceptibility to spore challenge in the presence of the LT-
responsive allele of Nlrp1b, excluding this gene as a candidate.
Interestingly, in the absence of an LT-responsive allele of Nlrp1b,
the loss of IL-4 resulted in a slightly higher resistance to anthrax
(Figure 4F).
Next, the role of IL-1b in Nlrp1b-mediated resistance to B.
anthracis Sterne was tested. LT dampens the host cytokine response
in the absence of LT-responsive Nlrp1b [9,10,33,34]. However, this
immunosuppression is not absolute and IL-1b contributes to
resistance to B. anthracis even in the absence of LT-responsive
Nlrp1b; animals expressing LT-resistant alleles of Nlrp1b and
lacking IL-1R or MyD88 (required for TLR and IL-1R signaling)
show increased sensitivity to infection by B. anthracis [35–38]. A
critical role for IL-1R was further validated in mice expressing LT-
responsive alleles of Nlrp1b [17]. However, it is still unknown
whether increased resistance to B. anthracis mediated by LT-
responsive alleles of Nlrp1b requires IL-1b. Of note, inflamma-
some-mediated resistance to Francisella tularensis is mediated by
both IL-1b and IL-18, and mice deficient in either cytokine are
resistant to tularemia, while those deficient in both IL-1b and IL-
18 are sensitive [39]. To address the mechanism by which Nlrp1b
mediates resistance to B. anthracis,B 6
Nlrp1b(129S1);IL-1R2/2 mice
were challenged with Sterne strain spores and viability was
compared to that of spore-challenged B6
IL-1R2/2 mice. Both
strains showed similar susceptibility to B. anthracis (Figure 4G),
indicating that Nlrp1b-mediated protection from anthrax requires
IL-1b signaling.
Severe LT-Induced ERP in B6.CAST.11 Mice Is Inherited in
a Recessive Manner
We previously demonstrated that a LT-responsive 129S1 allele
of Nlrp1b is sufficient to drive the ERP in B6
Nlrp1b(129S1) mice [15].
The CAST/Ei allele of Nlrp1b is also LT-responsive, though
distinct from the 129S1 allele [14]. To determine the contribution
of the CAST/Ei allele of Nlrp1b in the B6.CAST.11 response to
LT, B6.CAST.11M mice were crossed to B6 animals, and the
Figure 3. The role of IL-4 in the Nlrp1b-mediated response to LT. A, Comparative maps of mouse chromosome 11 B6.CAST strains. Thin
horizontal lines indicate homozygous B6 sequence, while thick boxes indicate homozygous CAST/Ei sequence. Physical locations are shown on top.
Vertical gray boxes denote QTL Ltxs1-3. Locations are as follows (physical / recombination boundaries): Ltxs2=63–69 Mb / 34.5 - 37 cM; Ltxs1=69.5–
71 Mb / 40–43 cM; Ltxs3=78–81 Mb / 44–46 cM. B, Mice deficient for the IL4 gene and expressing a LT-sensitive allele of Nlrp1b (B6
Nlrp1b(129S1)/IL4
2/2)
(n=7), mice deficient for the IL4 gene and expressing a LT-resistant allele of Nlrp1b (IL4
2/2) (n=7) were injected i.p. with 15 mgP A +7.5 mg LF per g
body weight, and body temperatures were monitored hourly. The lowest temperature observed during the first 6 h post toxin injection is plotted as
mean values +/2 SD. Data for controls (B6, B6
Nrlp1b(129S1) and B6.CAST.11M) are re-graphed from Figure 1B for comparison to IL-4
2/2. Lack of IL4 did
not significantly alter response to LT compared to matched control groups. C, B6 (n=5), B6
Nlrp1b(129S1) (n=5), and B6
Nlrp1b(129S1)IL-R
2/2 (n=10) mice
were challenged i.p. with 15 mgP A +7.5 mg LF per g body weight and the lowest temperature observed during the first 6 h post toxin injection is
plotted +/2 SD. Lack of IL1R did not significantly alter response to LT in mice transgenic for Nlrp1b. **p,0.01 compared to B6 control.
doi:10.1371/journal.ppat.1002469.g003
Host Genetic Control in Anthrax and Inflammation
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challenged with LT. LT-responsive alleles of Nlrp1b behave in a
fully dominant and penetrant manner in controlling activation of
caspase-1 and resulting macrophage pyroptosis [14,26]. We
therefore predicted that if allelic variation of Nlrp1b was
responsible for the exacerbated ERP displayed by B6.CAST.11
mice, [B6.CAST.11M x B6] F1 offspring expressing one CAST/Ei
allele of Nlrp1b would display an ERP equal in strength to the ERP
presented by B6.CAST.11M mice. Strikingly, F1 animals dis-
played the ERP at a much weaker strength (Figure 5). Thus, the
ERP observed in B6.CAST.11 mice is controlled by a gene or
genes that behave in a recessive fashion.
Critical Region Encoding Modifiers of the LT-Induced ERP
Isolated to 66.36–74.67 Mb Region on Chromosome 11
To refine the critical region controlling the increased inflam-
matory response to LT, we undertook a positional cloning
strategy. B6.CAST.11M mice were crossed to B6, and the
resulting [B6.CAST.11M x B6] F1 mice were backcrossed to
B6.CAST.11M animals. Backcross progeny (n=139) were intox-
Figure 4. B6.CAST.11M mice display increased resistance to infection by B. anthracis Sterne. A, Kaplan-Meier analysis of B6.CAST.11M
(n=8)(circles), B6
Nrlp1b(129S1) (n=8)(triangles), or nontransgenic littermate control mice (n=8)(squares) challenged i.p. with 3610
7 spores of B.
anthracis Sterne strain 7702. Survival curve p,0.0001 for both experimental groups compared to B6 control. B, Kaplan-Meier analysis of B6.CAST.11M
(n=8)(circles) or B6
Nrlp1b(129S1) (n=8)(triangles) challenged i.p. with 4610
8 spores of B. anthracis Sterne strain 7702. Survival curve p=0.0126. C&D ,
For cellular analyses at infection site following spore challenge, animals were euthanized at the indicated time points and the number of PMNs (C)
and monocytes (D) in the peritoneal cavity were determined as described in the Materials and Methods section. Data represent mean values (n=3
except, n=2 for B6.CAST.11M at 72 h and B6
Nrlp1b(129S1) at 135 h, and n=0 for B6 at 135 h) 6 SD. Differences in PMN counts were significant as
indicated: [t=4 h, p=0.025 B6.CAST.11M vs B6; p=0.003 B6
Nrlp1b(129S1) vs B6; p=0.04 B6.CAST.11M vs B6
Nrlp1b(129S1)] [t=28, p=0.016 B6
Nrlp1b(129S1) vs
B6; p=0.038 B6.CAST.11M vs B6]. Data for B6 animals at 135 h is absent as no B6 mice survived until this time point. E, Kaplan-Meier analysis of
B6
Nlrp1b(129S1)/IL4
2/2 (n=10) and B6
Nlrp1b(129S1) (n=10) mice challenged i.p. with 1.14610
8 spores of B. anthracis Sterne strain 7702. F, Kaplan-Meier
analysis of IL4
2/2 (n=14) and B6 animals (n=11) challenged i.p. with 2.42610
7 spores of B. anthracis Sterne strain 7702 (right panel). Survival curve,
p=0.033 G, Kaplan-Meier analysis of IL1R
2/2 mice with (n=10) and without (n=9) LT-sensitive 129S1 allele Nlrp1b challenged with 1.8610
6 spores of
B. anthracis Sterne strain 7702. Animals were monitored for 14 days for survival.
doi:10.1371/journal.ppat.1002469.g004
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temperature (Figure 6A). To correlate phenotype with genotype
within the chromosome 11 critical region, backcross progeny were
genotyped at multiple positions along the critical region using
chromosome 11 microsatellite markers (Figure 6B). A subset of
mice displaying a robust ERP following LT challenge, as
evidenced by a body temperature less than 30uC and severe
walking ataxia score, was heterozygous (i.e. CAST/Ei and B6) at
multiple microsatellite markers localized within the original critical
region on Chromosome 11 (Figure 6B). Conversely, several mice
displayed a weak ERP, as evidenced by a body temperature
greater than 34uC and mild walking ataxia score, despite retaining
homozygous CAST/Ei alleles over a significant fraction of the
critical region (Figure 6B). Comparison of the genotypes of these
groups of mice revealed that a gene(s) that modifies host response
to LT lies within the 66.36–74.67 Mb region on chromosome 11.
To identify candidate genes that contribute to host response to
LT from the 273 genes in the current critical region, we employed
expression quantitative trait locus (eQTL) analysis [40–42]. This
approach relies on the hypothesis that differential gene expression
is linked to phenotypic changes [40–43]. Transcript levels can be
analyzed as genetic traits in the same way that phenotypes such as
LT sensitivity can be analyzed [44,45]. Using a single, large cross
between two strains of mice, genetic loci, i.e. eQTL, that control
differential transcript levels can be mapped. Importantly, data
from a single experiment can be analyzed iteratively to identify a
unique eQTL associated with every gene with an altered transcript
level. If the transcript levels are controlled by structural variation
of a gene that influences its rate of transcription or the maturation
or stability of the transcript, the eQTL would be expected to map
directly over the gene in question. Such an eQTL is termed a cis-
acting eQTL. The approach of examining the segregation of
transcript levels in a genetic cross should be distinguished from a
study in which transcript levels are simply compared between two
different strains. In the latter study, differences in transcript levels
can be identified, but it is not possible to determine from such data
whether any differences observed are the result of cis-acting genetic
differences or trans-acting differences. In contrast, the combined
genetic/gene expression approach makes it possible to identify
genes and pathways that are perturbed by the cis- acting genetic
variations.
Analysis of a dataset consisting of over 1,600 microarray
experiments performed on 442F2 (B6 x CAST/EiJ) mice identified
81 cis-acting eQTL with a LOD score .4.3 within the refined
critical region (Table S1). Comparison of genomic sequences of
CAST/EiJ and B6 revealed multiple single nucleotide polymor-
phisms (SNPs) within the predicted mature mRNA sequences of
74 of the 81 eQTL, including non-synonymous changes in the
coding regions (not shown). Further refinement based on reported
gene function and expression pattern resulted in a list of 25 high-
priority candidate genes (i.e., genes known to participate in
immune or inflammatory processes) (Table S1).
Discussion
We previously reported a role for a LT-sensitive Nlrp1b allele in
controlling an inflammatory response to LT that we termed the
ERP [15]. This response was characterized by the release of
proinflammatory cytokines, noticeable ataxia and a reduction in
body temperature that were not present in B6 animals encoding
only LT-resistant alleles of Nlrp1b [15]. The ERP reported here in
multiple B6.CAST.11 strains was more severe compared to the
response exhibited by B6
Nlrp1b(129S1) animals (Figure 1A, B), and
this correlated with increased resistance to B. anthracis (Figure 4B).
Two models exist that may explain the altered response to LT
between B6.CAST.11 and B6
Nlrp1b(129S1) animals. First, variation
between CAST/Ei and 129S1 alleles of Nlrp1b may directly
contribute to ERP severity. Indeed, the current critical region
contains Nlrp1b, and CAST/Ei alleles of this gene are LT-
responsive yet genetically distinct from other LT-responsive alleles
[14]. However, this explanation would require that CAST/Ei
alleles of Nlrp1b contribute to phenotypes, such as response to
MDP + LPS (Figure 1E, F), not currently associated with the
Nlrp1b inflammasome. Further, two established mechanisms by
which inflammasomes drive innate immune responses, macro-
phage pyroptosis (Figure 1D) and cytokine responses (Figs. 1F,
2), cannot account for altered severity of host response to LT in
B6.CAST.11 mice. Finally, [B6.CAST.11M x C57BL/6] F1 mice
showed loss of the severe LT-induced ERP (Figure 5), indicating
a recessive mode of inheritance that is inconsistent with the well-
established dominance of LT-sensitive alleles of Nlrp1b [14,26].
Interestingly, the ataxia scores in F1 mice match those seen in
C57BL/6
Nlrp1b(129S1) transgenic mice, consistent with retention of
one dominant LT-responsive allele of Nlrp1b, and further
suggesting that both CAST/Ei and 129S1 alleles do in fact
function in a similar, dominant manner to drive a less severe ERP.
Therefore, we propose a second model, wherein at least one
additional gene in the critical region of chromosome 11 is required
for full expressivity of the ERP and high-level resistance to spore
challenge. While we cannot exclude a novel role in inflammation
and/or mechanism of action for the CAST/Ei allele of Nlrp1b, the
findings presented here are more consistent with contributions by
an additional gene. Of note, this model does not rule out the
possibility that multiple or different genes contribute to the host
response to MDP + LPS, LT, and/or spores. Indeed, the critical
region contains numerous genes with established or proposed roles
in inflammation (Table S1).
Three murine QTL, Lethal toxin sensitivity 1-3 (Ltxs1-3), and one
gene, Nlrp1b (within Ltxs1), have been reported to control
Figure 5. Severity of LT-induced ERP is controlled by a gene(s)
on chromosome 11. A, B6.CAST.11M (n=4), B6 (n=4), B6
Nrlp1b(129S1)
(n=14) and [B6.CAST.11M x B6] F1 (n=14) animals were challenged i.p.
with LT and responses scored as described above. Nonparametric
analysis performed using Kruskal-Wallis nonparametric test with Dunn’s
post test.
doi:10.1371/journal.ppat.1002469.g005
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Although backcross mapping data presented here eliminates a role
for Ltxs3 contributing to the ERP, it is possible that one or more
genes within Ltxs1 and/or 2 contribute to the severity of this
phenotype. Notably, while the gene at Ltxs1 responsible for
macrophage pyroptosis was identified as Nlrp1b [14], a dominantly
inherited resistance to LT was also mapped to this region [46],
indicating that more than one overlapping QTL may exist at
Figure 6. Refining the chromosome 11 critical region bestowing the LT-Induced ERP. A, Body temperature recordings of backcross
progeny (n=139) as well as B6.CAST.11M (n=21), B6
Nrlp1b(129S1) (n=5) and B6 control mice (n=5) following i.p. injection of 15 mgP A +7.5 mg LF. Mice
were monitored as previously described. B, Backcross progeny genotypes at microsatellite markers on chromosome 11 were determined by PCR as
described in Methods. Lowest body temperature for each animal following LT challenge was determined as described above.
doi:10.1371/journal.ppat.1002469.g006
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Ltxs1 and Ltxs2 [46], allelic variation in B6.CAST.11 animals does
not alter susceptibility to LT, defined as time to moribund
behavior, compared to B6 mice (Figure 1C). Therefore, we
propose that additional QTL influencing host response to LT
reside within this critical region.
In order to identify candidate genes within the critical region
that potentially contribute to ERP and resistance to B. anthracis
Sterne, we mined a gene expression dataset from a B6 x CAST/
EiJ F2 cross for cis-acting eQTL. Variation in basal transcription
levels of genes within a disease QTL has been used previously to
identify candidate genes controlling phenotypic variation [42,48].
Given the rapid response to LT, as quickly as 18 minutes post i.v.
challenge, we reasoned that alterations in basal gene expression
levels and/or protein activity could account for altered ERP
strength between B6.CAST.11M and C57BL/6
Nlrp1b(129S1) trans-
genic mice. We further refined the selection criteria for candidate
genes to include the presence of single nucleotide polymorphisms
within the coding region and known association of candidate genes
with inflammatory responses. Finally, we considered other genes
previously identified as candidates for host response to LT. The
gene encoding inducible nitric oxide synthase (iNOS/NOS2) was
previously studied with respect to host response to lethal toxin and
was identified as overlapping with Ltxs3 [24,36,46,49]. However,
Nos2 falls outside the critical region reported here and was
therefore excluded. Within the current critical region, one gene,
Mgl1/Clec10a, and one QTL controlling susceptibility to Salmo-
nella infection, Ity2, were proposed as candidates for controlling
host response at Ltxs2 [46]. Mgl1/Clec10a, and the neighboring
Mgl2, were identified here as high-priority candidates as they
encode galactose/N-acetyl-galactosamine binding lectins ex-
pressed on alternatively activated macrophages [50]. Alternatively
activated macrophages modulate inflammatory responses and
Mgl1
2/2 mice displayed more severe inflammation in a model of
experimental colitis [51].
From the list of high priority eQTL candidates, it is noteworthy
that several play a role in inflammatory responses by acting through
lipid mediators. Alox8, Alox12e and Alox15 belong to a family of
arachidonate lipoxygenases responsible for production of anti-
inflammatory lipoxins from arachidonic acid. Lipoxins are
predicted to suppress vascular changes induced by inflammatory
mediators [52]. Similarly, proteins encoded by phospholipase D2,
Pld2, phospholipid scramblase 3, Plscr3, phosphoinositide-3-kinase,
regulatory subunit 6 Pik3r6, and spinster homolog 2, Spns2, are
involved in phospholipid synthesis and/or signaling events
associated with inflammatory responses including leukocyte migra-
tion, phagocytosis, oxidative burst, and vascular permeability.
b-arrestin 2 (Arrb2) and netrin 1 (Ntn1) are two additional high
priority candidates, and are involved in signaling in response to
inflammatory stimuli [53–56]. Indeed, Arrb2 regulates LPS-
induced inflammatory response and endotoxemia [54,55], while
Ntn1 can minimize inflammatory damage associated with
ischemia-reperfusion injury [56]. Additional eQTLs were identi-
fied in mediators of host innate immunity, including complement
C1q binding protein, C1qBP, and the chemokine CXCL16.
CXCL16 is elevated in patients with inflammatory bowel disease,
and Cxcl16
2/2 mice display less inflammation in a murine model
of enterocolitis [57]. Platelet-activating factor acetylhydrolase,
isoform 1b, subunit 1 (Pafah1b1), another high-priority candidate,
was implicated in susceptibility to necrotizing enterocolitis in
humans, and Pafah1b1 deficiency in mice led to increased
susceptibility to this disease [58]. Finally, two eQTLs were
identified that have opposite functions in protein metabolism.
Eukaryotic initiation factor 4A-I, Eif4a1, is a component of the
ribosome involved in protein translation, while Psmb6 (proteasome
(prosome, macropain) subunit, beta type 6) is a component of the
proteasome involved in protein degradation. Interestingly, PSMB6
is replaced by an alternative proteasome subunit, LMP2, to form
an ‘‘immunoproteasome’’ in response to interferon signaling, and
has been identified as a candidate gene contributing to
autoimmune type-1 diabetes in mice [59].
While differential gene expression has been used extensively
with positional cloning efforts to identify candidate genes
[42,59,60], it is possible that genes responsible for ERP and
resistance to B. anthracis Sterne infection are not differentially
regulated at the level of transcription. For example, the critical
region encodes two paralogues of Nlrp1b, Nlrp1a and Nlrp1c, that
were not identified as cis-acting eQTL. Very little is known
regarding these paralogues, and it is possible that they have a role
in the increased severity of ERP seen in B6.CAST.11 animals.
NLRP1B inflammasome formation allows for the processing
and extracellular release of proinflammatory cytokines. The LT-
induced ERP is coupled with the induction of several cytokines, of
which IL-1b is one of the earliest detectable in the sera of
intoxicated mice (Figure 2). IL-1b activity was not required for
the ERP, as LT-challenged B6
Nlrp1b(129S1);IL-1R2/2 animals showed
ataxia and hypothermic responses that were indistinguishable from
B6
Nlrp1b(129S1) mice (Figure 3C). Interestingly, B6.CAST.11M, but
not B6 mice challenged i.p. with recombinant IL-1b displayed
ataxia (J.K.T. and S.M.L., unpublished observation), suggesting
that this cytokine is sufficient but not necessary to bestow the ERP.
In contrast, IL-1R deficient B6
Nlrp1b(129S1) mice were equally
susceptible to infection compared to IL-1R deficient mice
expressing only B6 alleles of Nlrp1b, demonstrating that this
cytokine is required for Nlrp1b-mediated resistance to B. anthracis.
In total, these data indicate that IL-1b plays different roles, i.e., for
the ERP it is sufficient but not necessary, but for resistance to
anthrax it is necessary. One interpretation is that NLRP1B-
mediated pyroptosis results in release of IL-1b that can induce
multiple other inflammatory cytokines and/or inflammatory
mediators that contribute, in a redundant manner, to ataxia,
hypothermia, and other ERP-associated clinical signs, but that
only a few are critical for resistance to B. anthracis. Indeed, we did
not observe TNFa release from LT-treated BMDMs (Figure 1F),
indicating that other cell types may be responsible for the TNFa
response, and possibly hypothermia, in LT-treated mice
(Figures 1B, 2). This may occur either directly, in response to
LT, or indirectly, in response to IL-1b. Conversely, TNFa, but not
IL-1b was released from BMDMs derived from all three mouse
strains in response to MDP/LPS under the conditions tested
(Figure 1F), consistent with a Nlrp1b-independent role for TNFa
in LPS-induced hypothermia. Whether the exacerbated response
of B6.CAST.11M mice to LT and MDP/LPS derive from a
common mediator, or whether these congenic mice are more
responsive to multiple mediators is not currently known. The
identities and mechanisms of action of such mediators are
currently under investigation.
Our understanding of the role of cytokines in response to LT
challenge and B. anthracis infection has recently changed. Studies
presented here and [15] indicate that cytokines are not a major
influence of mortality in response to purified LT injection as once
thought, and we find no evidence of alterations in time-to-death as
a result of Nlrp1b allele status. In contrast, a modest influence of
LT-responsive alleles of Nlrp1b has been reported in a different
murine intoxication model [17,24]. Regardless of the role of
cytokines in response to LT challenge, it is clear that IL-1b is
critical for resistance during infection with B. anthracis Sterne
[17,36,37,61]. Importantly, we extend these prior findings and
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protection from infection bestowed by LT-responsive alleles of
Nlrp1b.
Septic shock and autoinflammatory diseases such as vitiligo,
Crohn’s disease, Muckle-Wells syndrome, and gout, among others,
result from overactive release of proinflammatory cytokines
including IL-1b [62]. Based on differential inflammatory response
to disparate stimuli such as LT and LPS/MDP, we propose that
B6.CAST.11 and B6
Nlrp1b(129S1) mice may provide a unique system
to further analyze inflammatory syndromes. Systemic Inflammatory
Response Syndrome (SIRS) is a term used for the generalized
inflammatory reaction that occurs in patients undergoing sepsis or a
non-septic trauma, such as pancreatitis, hemorrhagic shock,
thermal injury, or severe surgery [63]. Accordingly, SIRS is defined
by the presentation of two or more of the following clinical markers
that match LT-induced ERP: a bodytemperature higher than 38uC
or lower than 36uC, endothelial dysfunction and increased
microvascular permeability, and platelet sludging causing maldis-
tribution of blood flow [64,65]. A second inflammatory syndrome,
Compensatory Anti-inflammatory Response Syndrome (CARS),
was more recently defined as a counter-regulatory response to the
overzealous inflammatory reaction that occurs in SIRS [29]. This
adaptive response is characterized by the increased induction of
anti-inflammatory molecules IL-10 and IL-4 [29]. Although
attenuation of inflammation may be beneficial in some instances,
CARS patients are often more susceptible to secondary bacterial
infections [29,66]. Interestingly, B6
Nlrp1b(129S1) transgenic mice
display a weaker ERP (Figure 1), are more susceptible to B.
anthracis infection (Figure 4), and release higher levels of IL-4 than
B6.CAST.11M mice in response to LT (Figure 2). Because the
gene encoding IL-4 resides at 53.4 Mb on chromosome 11 (part of
the original critical region), we tested the role of this cytokine in the
differential response to LT. B6
Nlrp1b(129S1);IL42/2 mice showed no
alteration in the ERP or resistance to B. anthracis compared to
B6
Nlrp1b(129S1) animals, indicating this cytokine cannot, on its own,
account for differences in hypothermia, ataxia, or resistance to B.
anthracis between B6
Nlrp1b(129S1) and B6.CAST.11M animals.
However, mice lacking both an LT-responsive allele of Nlrp1b and
the IL4 gene were slightly more resistant to B. anthracis spores
compared to B6 animals (Figure 4F), suggesting a negative role for
Th2 responses in the outcome of B. anthracis infection. Further
mapping confirmed that IL4 lies outside the current critical region
(Figure 6), eliminating it as a candidate involved in the regulation
of the ERP. Notably, IL-10 levels were equivalent between
B6
Nlrp1b(129S1) and B6.CAST.11M mice following LT challenge
(Figure 2). Therefore, we hypothesize allelic variation of gene(s) in
the chromosome 11 critical region represent a novel genetic control
mechanism for a SIRS/CARS like inflammatory response to LT.
B6.CAST.11M mice further showed increased responsiveness to a
MDP + LPS model of sepsis compared with B6 controls
(Figure 1E), indicating that gene(s) within the critical region may
play a role in multiple inflammatory syndromes including sepsis.
Currently,nosingle treatmentforsepsis exists[67],andthereislittle
understanding of mechanisms driving resolution of shock/sepsis
[68,69]. We predict that identification of genetic and molecular
mechanisms controlling severity of LT-induced ERP and/or host
response to MDP + LPS will provide insight into novel intervention
strategies for sepsis and other inflammatory diseases.
Materials and Methods
Animal Maintenance and Breeding
All studies involving the use of mice were conducted in
compliance with the Animal Welfare Act and other federal
statutes and regulations relating to animals and experiments
involving animals and adheres to principles stated in the Guide for
the Care and Use of Laboratory Animals, National Research
Council, 1996. All studies involving the use of mice were approved
by the University of California Animal Research Committee and/
or the USAMRIID Animal Care and Use Committee (Permit
numbers: 2005-122 and 2007-019). UCLA and USAMRIID are
fully accredited by the Association for the Assessment and
Accreditation of Laboratory Animal Care International.
B6 and CAST/EiJ mice were purchased from the Jackson
laboratory (Bar Harbor, ME). Transgenic mice expressing a
129S1/SvImJ (129S1)-derived LT
S allele of Nlrp1b/Nalp1b on a
LT-resistant (LT
R) B6 background (B6
Nlrp1b(129S1)) and backcrossed
to B6 for seven generations were obtained from Drs. E. Boyden
and W. Dietrich (Harvard Medical School) [14,15]. B6
Nlrp1b(129S1)
mice both heterozygous and homozygous for the Nlrp1b transgene
were used for experiments reported here as no difference in
response to LT or Sterne spores was observed. The library of
congenic mice consisting of introgressed segments of CAST/Ei
DNA on a B6 background (B6.CAST) has been described [25].
B6.CAST.11M mice were crossed to B6 to obtain [B6.CAST.11M
x B6] F1 offspring used for intoxication experiments and for
determining the mode of inheritance. Backcross progeny were
generated by crossing B6.CAST.11M mice to B6 mice, and
backcrossing the [B6.CAST.11M x B6] F1 mice to B6.CAST.11M
mice.
Mouse Genotyping
Genomic DNA was isolated from tail biopsies using Qiagen
DNeasy blood and tissue kit. Presence of Nlrp1b(129S1) transgene
was monitored as previously described [15]. Mutant and wild type
alleles of Il1r1 were identified using PCR primers oIMR000160,
oIMR0161, oIMR7898, and oIMR7899 as per supplier’s protocol
(Jackson Laboratory, Bar Harbor, ME). Mutant and wild type
alleles of Il4 were identified using PCR primers oIMR0077,
oIMR0078, and oIMR0079 (Jackson Laboratory, Bar Harbor,
ME). [B6.CAST.11M x B6] F1 x B6.CAST.11M backcross
progeny were genotyped at multiple positions within the region
of interest using chromosome 11 microsatellite markers that
distinguish CAST/Ei and B6 alleles (Mouse Genome Informatics
(MGI) database (http://www.informatics.jax.org)). All 139 back-
cross progeny were genotyped at D11MIT190 (47.6 Mbp),
D11MIT131 (55.9 Mpb), D11MIT260 (61.6 Mbp), D11Die36
(70.9 Mbp), D11MIT357 (90.1 Mbp), and D11MIT199 (101.7
Mbp) by PCR and gel electrophoresis. Backcross progeny that
displayed genetic recombination within this region and/or
presented with a strong ERP were further genotyped at the
polymorphic microsatellite markers indicated in Figure 6B.
Toxin Preparation
LT components were expressed and purified as previously
described [15]. Specifically, the PA expression plasmid, PA-
pET22b was provided by Dr. John Collier (Harvard Medical
School) and transformed into Escherichia coli BL21 DE3 cells. A
fresh colony was inoculated into a 20 mL starter culture of Luria
Bertani (LB) Lennox media (EMD Biosciences, Inc.) with 100 mg/
mL ampicillin and grown overnight at 37uC. The following day a
1:50 dilution was made into a 2 L baffled Erlenmeyer flask of LB
Lennox supplemented with 100 mg/mL ampicillin. The culture
was grown at 37uC and shaking at 250 rpm until an optical density
of 1.0 was reached. The culture was then induced with a final
concentration of 1 mM isopropyl b-D-1-thiogalactopyranoside
and allowed to grow at 30uC and shaking at 250 rpm for 4 h. PA
was isolated from the periplasm and purified over a Macro-Prep
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megaterium was obtained from Dr. Jeremy Mogridge (University of
Toronto), and resuspended in pharmaceutical grade saline for all
animal experiments. A dose of 5 mg PA and 2.5 mg LF per g body
weight was diluted in pharmaceutical grade saline and injected i.p.
Alternatively, PA and LF were purified from B. anthracis strain
BH450 as described [70]. LF produced from strain BH450
displayed 3-fold lower activity [71], and consequently a dose of
15 mg PA and 7.5 mg LF per g body weight was used to achieve a
similar mortality rate [15]. Endotoxin was removed from PA and
LF protein preparations using the Detoxi-Gel Endotoxin Remov-
ing Gel (Pierce). Purified proteins were assayed for endotoxin using
the Limulus Amebocyte Lysate kit (BioWhittaker/Lonza Biosci-
entific), which detects a minimum of 0.03 endotoxin units/mL.
Lethal Toxin Challenge
A total of 36 B6.CAST congenic strains were screened for LT
response. For each strain, ,5 mice of mixed gender and ,8 weeks
of age were administered LT by i.p. injection at a dose that
induced mortality in B6 control animals with a mean time to death
of ,60 h (see above). Larger-scale secondary screens were
performed using 5–10 additional animals of each candidate or
control strain. Upon injection, mice were closely monitored for
,2 h and then every 2–3 h for clinical signs consisting of ataxia,
bloat, lethargy, loose feces and/or hunched posture. Ataxia was
measured using a grading system in which mice were scored as
displaying a mild, moderate, or severe phenotype. A mild
phenotype was defined as reduced exploratory behavior or rearing
on hindlimbs, a slower and/or less steady gait, but free ambulation
throughout the cage. A moderate score was defined as a preferred
sedentary state, but the mouse was able to generate a slow,
unsteady (e.g. wobbly) gait for up to ,7 sec before resting. A
severe score was defined as a stationary state, but upon stimulation
the mouse could generate a few unstable steps (e.g. severe wobble
and/or tremor) before stopping.
For experiments focused on the acute presentation of clinical
signs, mice were closely monitored for ,6–8 hours then
euthanized. Mouse body temperatures were measured following
LT injection using a rectal thermometer probe. Baseline
temperatures were determined prior to LT injection and no
differences were observed between animal groups (not shown).
Temperatures were recorded hourly for up to 7 h following LT
injection. Some mice were injected i.p. with recombinant murine
IL-1b (R & D Systems) at a dose of 100 ng per mouse immediately
prior to LT injection and observed as described above.
In vitro BMDM intoxication studies were performed as
previously described [72]. Briefly, bone marrow was flushed from
femur and tibia bones of 8-week old mice using DMEM
supplemented with 10% fetal bovine serum (FBS) and 1%
penicillin-streptomycin-glutamine (PSG) cocktail (Invitrogen).
Marrow was then briefly centrifuged at 1500 rpm and resus-
pended in 1x ACK Lysis Buffer (150 mM NH4Cl, 1 mM
KHCO3, 100 mMN a 2-EDTA, pH 7.2) for 5 min. Cells were
briefly centrifuged at 1500 rpm and resuspended in DMEM
supplemented with 10% FBS, PSG, and 2% conditioned medium
of CMG14-12 cells as a source of M-CSF. Ten million cells were
seeded per 15 cm plate and incubated at 37uC, 5% CO2 for 6–7
days, then harvested and seeded at 5610
4 cells per well in a 96
well plate in DMEM supplemented with 10% FBS, PS cocktail
(Invitrogen), 25 mM HEPES, and Glutamax (Invitrogen). PA and
LF were titrated in a final volume of 100 mL / well and incubated
for 4 h prior to addition of ATPlite 1-step reagent (PerkinElmer,
Waltham, Massachusetts). Luminescence intensity was measured
using Victor 3V (PerkinElmer) plate reader. Alternatively,
BMDMs were exposed to 0.1 mg/mL MDP and 0.1 ng/mL LPS
for 8 hr [27], or 250 ng/mL PA and 250 ng/mL LF for 3 hr prior
to collecting cell culture supernatant for cytokine analysis.
Cytokine Analysis
For cytokine analysis, mice were injected i.p. with LT at a dose
of 15 mg PA and 7.5 mg LF per g body weight. Blood was collected
via cardiac puncture and allowed to coagulate for ,1 h. Samples
were centrifuged, and sera was collected and stored at 280uC.
Cytokines were detected using the Millipore Milliplex MAP
Mouse Cytokine Kit per manufacturer’s instructions and read on a
Luminex 100 IS or BioRad Bioplex 200 instrument. Serum from
each mouse was analyzed in duplicate and average values from
these independent measurements were used to calculate a mean
for each animal group (n=5). For BMDM experiments, at least
two independent mice per strain were used, and cells from each
mouse were tested in duplicate. All cytokine data were analyzed
using MILLIPLEX Analyst software (EMD-Millipore) with five
parameter logistic curve fitting.
Spore Challenge and Cellular Analysis Experiments
B6.CAST.11M, B6
Nlrp1b(129S1), and non-transgenic littermate/
cagemate (i.e. B6) mice were challenged with unencapsulated,
toxigenic Sterne strain (7702) by i.p. injection as indicated in figure
legends and monitored daily for 14 days. B6.CAST.11M,
B6
Nlrp1b(129S1), and B6 mice were also used for peritoneal cellular
infiltration determination following spore challenge. For cellular
analysis, mice were infected i.p. with ,1.6610
7 Sterne spores and
euthanized at 4, 28, 52, 76, and 135 h post infection. Uninfected
mice were used to determine baseline cell populations in the
peritoneal cavity of each strain (t=0). Peritoneal exudates from
infected mice were harvested by injecting 7 ml sterile HBSS and
3 ml air into the peritoneal cavity. The fluid was agitated within
the cavity and then extracted. The fluids were analyzed as follows
from three mice per group at each time point, except where
indicated. Total cell counts were determined microscopically by
using a hemocytometer; four fields for each mouse were counted
and averaged. The cells from an aliquot of sample were then
collected onto slides with a Cytospin centrifuge (Shandon, Inc.,
Pittsburgh, PA). The slides were fixed in methanol, stained with
Diff-Quik (Harleco, Philadelphia, PA), and then evaluated
microscopically to determine the percentages of cell types (i.e.,
percentages of monocytes, PMN). The average % of each cell type
per mouse group was calculated, and the total number of each cell
type was determined by multiplying the mean proportion of each
cell type by the mean hemocytometer count for each mouse group.
These values were plotted including standard deviation for each
mouse group.
Expression QTL Analysis
Comprehensive mapping of gene expression in adipose, brain,
liver and muscle of 442 F2 progeny of a cross between C57BL/6J
and CAST/Ei mice was previously described [73]. From this
dataset, we selected genes with strong (LOD .4.3) cis-acting
expression-QTLs located in the region between 66.36 and 74.67
on Chromosome 11. Peak LOD scores for each tissue are reported
on Table S1. Gene names, positions, and functions were
compared to NCBI build 37.1 and MGI annotation datasets.
Genes were prioritized by biological function as determined by
MGI genome analysis tools (www.informatics.jax.org/tools.shtml)
combined with manual curation (www.ncbi.nlm.nih.gov/gene). B6
and CAST/Ei nucleotide sequences were compared using fully
sequenced genomes from each strain available at http://www.
sanger.ac.uk/cgi-bin/modelorgs/mousegenomes/snps.pl to iden-
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genetic divergence between these strains, 64,102 SNPs were
identified between 63.36–74.67 Mbp. The search was refined to
analyze only predicted mRNA sequences, resulting in 2,421 SNPs
that mapped to 74 out of the 81 eQTL.
Supporting Information
Table S1 Candidate genes within the critical region on
chromosome 11. Dataset analysis of over 1,600 microarray
experiments performed on 442 F2 (B6 x CAST/EiJ) mice revealed
81 cis-acting eQTL (differences in gene expression map to
structural changes in genes themselves). Of the 81, 25 (shown in
bold) were identified as high priority candidates based on their
known or predicted functions in inflammation and/or immuno-
logical processes. In addition, the critical region encodes Nlrp1a,
and Nlrp1c, which were not analyzed by microarray, but which are
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